Recently, the RAS-RAF-MAP kinase signaling pathway has been implicated in many cancers, particularly more frequently in thyroid carcinomas, with the BRAF V600E mutation playing a vital role in papillary thyroid carcinoma. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.